Cardiff Oncology Inc. (CRDF)
NASDAQ · Healthcare
Cardiff Oncology Inc. Shareholder Equity 2011–2025
Cardiff Oncology Inc. annual shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Cardiff Oncology Inc. shareholder equity as of December 31, 2025: 45.4M, a 45.28% decrease year-over-year.
- Cardiff Oncology Inc. shareholder equity for 2025 were 45.4M, a 45.28% decrease from 2024.
- Cardiff Oncology Inc. shareholder equity for 2024 were 82.9M, a 18.94% increase from 2023.
- Cardiff Oncology Inc. shareholder equity for 2023 were 69.7M, a 34.42% decrease from 2022.
- Cardiff Oncology Inc. shareholder equity for 2022 were 106.3M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Cardiff Oncology Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $45 |
| 2024 | $83 |
| 2023 | $70 |
| 2022 | $106 |
| 2021 | $140 |
| 2020 | $128 |
| 2019 | $7 |
| 2018 | $10 |
| 2017 | $7 |
| 2016 | $20 |
| 2015 | $49 |
| 2014 | $8 |
| 2013 | $20 |
| 2012 | $2 |
| 2011 | $-4 |
Cardiff Oncology Inc. Shareholder Equity — FAQ
Cardiff Oncology Inc. (CRDF) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRDF's shareholder equity history?
The chart and table above show Cardiff Oncology Inc.'s shareholder equity by year and by quarter, including the growth rate.